Pablo

What moved my ApoB? An honest cross-reference

ApoB went 118 → 75 → back to 95 → 82. I lined every swing up against my dose-period history. One correlate survives; no proof.

#apob#lipids#bloodwork

The swings

dateApoBLDL (calc)Total cholHDL
2023-12-0794.2125.419761
2024-10-31118.2130.620463
2025-06-0596.9136.222072
2025-07-29115.819065
2025-10-2975.4105.218064
2025-12-1695.1132.821065
2026-03-1281.9111.019168

Triglycerides stayed 46–65 throughout — never part of the story. | 2026-06-11 | 84.7 | 120 | 205 | 72 |

Lining the swings up against the stack

Context that holds still: diet has been the same for years — high-protein Mediterranean, extra-virgin olive oil as the main fat. So food is off the suspect list for every swing below. Training was steady too (full-body gym 2–4×/week + sports for cardio), with two exceptions that matter.

The 118 peak (Oct 2024): that draw sits in my back-problem year — for a good chunk of 2024 I trained much less, sometimes not at all. A deconditioned stretch is a credible explanation for the worst ApoB reading in the series.

The big drop (Jun → Oct 2025, ApoB 97 → 75): training and diet normal and stable. Started in that window — TMG (Jun–Jul), methyl B-12 daily (Jun 20 → Oct 1), akkermansia (Jul 21 → Oct 19), selenium EOD + boron 6 mg (Aug 9), L-tyrosine (Sep 9). The mid-window draw (Jul 29) shows most of the LDL drop had already happened by late July.

The rebound (Oct → Dec 2025, ApoB 75 → 95): stopped akkermansia (Oct 19), dropped B-12 from daily to ~weekly (Oct 1). TMG restarted at 2 g (Nov 11) and didn't prevent it. Training unchanged.

The re-improvement (Dec → Mar 2026, ApoB 95 → 82): B-12 back to daily (Jan 20), selenium daily (Jan 20), methylfolate added (Jan 22) — and from February, tennis elbow ended sports but pushed gym volume UP to 4–5 full-body sessions a week. Two things changed at once; this leg can't separate them.

What survives, and what I can't claim

With diet stable for years, the cleanest evidence is the 2025 mid-year drop and the autumn rebound — both under unchanged training: methyl B-12 taken daily is present in every low-ApoB phase and sparse or absent in the rebound. Akkermansia fits 2025 but I re-improved in 2026 without it. The 2024 peak now has a rival explanation (the low-training back year), and the 2026 re-improvement is confounded by the training increase after tennis elbow took sports away.

What this is not: proof. Nothing was controlled, the readings are quarterly at best, and homocysteine doesn't co-move the way a clean methylation story would predict (it spiked in Mar 2026 while ApoB improved). Correlation from one person's log, nothing more.

Update, 2026-06-11: ApoB drifted to 84.7 (LDL 120). Nothing changed in the stack; the draw followed a short-sleep week and I'd let training slip a little around it. Consistent with the rest of this log — the swings are real but small, and no single input owns them.